Ashraf A Sabe1, Nassrene Y Elmadhun1, Ahmed A Sadek1, Louis M Chu1, Cesario Bianchi1, Frank W Sellke2. 1. Division of Cardiothoracic Surgery, Cardiovascular Research Center, Warren Alpert School of Medicine, Brown University, Providence, RI. 2. Division of Cardiothoracic Surgery, Cardiovascular Research Center, Warren Alpert School of Medicine, Brown University, Providence, RI. Electronic address: fsellke@lifespan.org.
Abstract
OBJECTIVES: The perioperative administration of pleomorphic statin drugs has been implicated in improving outcomes after cardiac surgery. Adaptive autophagy is a highly conserved cellular process that allows for the elimination of dysfunctional cell components in response to stress and survival under starving conditions. We sought to investigate the effects of the statin drug atorvastatin on autophagy in ischemic and nonischemic myocardia using a clinically relevant porcine model of metabolic syndrome. METHODS: Male Ossabaw swine were fed a regular diet (n = 8), a high-cholesterol diet (n = 8), or a high-cholesterol diet with supplemental atorvastatin (1.5 mg/kg/d) (n = 8). After 14 weeks, all animals underwent surgical placement of an ameroid constrictor to the circumflex coronary artery to induce chronic ischemia. Nonischemic and ischemic myocardia were harvested 6 months after initiation of the diet and processed for Western blotting. RESULTS: In the nonischemic myocardium, Western blot results demonstrate that a high cholesterol diet resulted in a statistically significant decrease in autophagy as indicated by an increase in mammalian target of rapamycin and the accumulation of several essential autophagy markers, including Beclin-1, light chain 3B-I, and light chain 3B-II. Atorvastatin supplementation prevented these changes and resulted in an increase in autophagy as indicated by a decrease in autophagy flux marker P62. In the ischemic myocardium, atorvastatin had the opposite effect, with a decrease in autophagy flux as indicated by an increase in p62 and an accumulation of light chain 3B-I, light chain B-II, and lysosome-associated membrane protein 2. CONCLUSIONS: Atorvastatin administration has differential effects on autophagy in ischemic and nonischemic myocardia. In the setting of metabolic syndrome, atorvastatin stimulates autophagy in nonischemic myocardium while partly inhibiting autophagy in ischemic myocardium. The differential regulation on autophagy may, in part, explain the cardioprotective effect of statins in both ischemic and nonischemic myocardia, and these findings may have implications in the setting of cardiac surgery.
OBJECTIVES: The perioperative administration of pleomorphic statin drugs has been implicated in improving outcomes after cardiac surgery. Adaptive autophagy is a highly conserved cellular process that allows for the elimination of dysfunctional cell components in response to stress and survival under starving conditions. We sought to investigate the effects of the statin drug atorvastatin on autophagy in ischemic and nonischemic myocardia using a clinically relevant porcine model of metabolic syndrome. METHODS: Male Ossabaw swine were fed a regular diet (n = 8), a high-cholesterol diet (n = 8), or a high-cholesterol diet with supplemental atorvastatin (1.5 mg/kg/d) (n = 8). After 14 weeks, all animals underwent surgical placement of an ameroid constrictor to the circumflex coronary artery to induce chronic ischemia. Nonischemic and ischemic myocardia were harvested 6 months after initiation of the diet and processed for Western blotting. RESULTS: In the nonischemic myocardium, Western blot results demonstrate that a high cholesterol diet resulted in a statistically significant decrease in autophagy as indicated by an increase in mammalian target of rapamycin and the accumulation of several essential autophagy markers, including Beclin-1, light chain 3B-I, and light chain 3B-II. Atorvastatin supplementation prevented these changes and resulted in an increase in autophagy as indicated by a decrease in autophagy flux marker P62. In the ischemic myocardium, atorvastatin had the opposite effect, with a decrease in autophagy flux as indicated by an increase in p62 and an accumulation of light chain 3B-I, light chain B-II, and lysosome-associated membrane protein 2. CONCLUSIONS:Atorvastatin administration has differential effects on autophagy in ischemic and nonischemic myocardia. In the setting of metabolic syndrome, atorvastatin stimulates autophagy in nonischemic myocardium while partly inhibiting autophagy in ischemic myocardium. The differential regulation on autophagy may, in part, explain the cardioprotective effect of statins in both ischemic and nonischemic myocardia, and these findings may have implications in the setting of cardiac surgery.
Authors: Leslie L Clark; John S Ikonomidis; Fred A Crawford; Arthur Crumbley; John M Kratz; Martha R Stroud; Robert F Woolson; James J Bruce; Joyce S Nicholas; Daniel T Lackland; Michael R Zile; Francis G Spinale Journal: J Thorac Cardiovasc Surg Date: 2006-03 Impact factor: 5.209
Authors: Lin Yan; Dorothy E Vatner; Song-Jung Kim; Hui Ge; Malthi Masurekar; William H Massover; Guiping Yang; Yutaka Matsui; Junichi Sadoshima; Stephen F Vatner Journal: Proc Natl Acad Sci U S A Date: 2005-09-20 Impact factor: 11.205
Authors: Allen M Andres; Genaro Hernandez; Pamela Lee; Chengqun Huang; Eric P Ratliff; Jon Sin; Christine A Thornton; Marichris V Damasco; Roberta A Gottlieb Journal: Antioxid Redox Signal Date: 2013-09-20 Impact factor: 8.401
Authors: Donna Mancini; Sean Pinney; Daniel Burkhoff; John LaManca; Silviu Itescu; Elizabeth Burke; Niloo Edwards; Mehmet Oz; Andrew R Marks Journal: Circulation Date: 2003-05-12 Impact factor: 29.690
Authors: Wei Pan; Tatjana Pintar; James Anton; Vei-Vei Lee; William K Vaughn; Charles D Collard Journal: Circulation Date: 2004-09-14 Impact factor: 29.690
Authors: Ashraf A Sabe; Brittany A Potz; Nassrene Y Elmadhun; Yuhong Liu; Jun Feng; M Ruhul Abid; Jinnette D Abbott; Donald R Senger; Frank W Sellke Journal: J Thorac Cardiovasc Surg Date: 2015-09-03 Impact factor: 5.209
Authors: Ashraf A Sabe; Nassrene Y Elmadhun; Ahmed A Sadek; Rahul S Dalal; Louis M Chu; Cesario Bianchi; Frank W Sellke Journal: J Card Surg Date: 2014-12-16 Impact factor: 1.620
Authors: Zoltán Giricz; Gábor Koncsos; Tomáš Rajtík; Zoltán V Varga; Tamás Baranyai; Csaba Csonka; Adrián Szobi; Adriana Adameová; Roberta A Gottlieb; Péter Ferdinandy Journal: Lipids Health Dis Date: 2017-03-23 Impact factor: 3.876